|
Trocoxil
|
75 mg
|
EU/2/08/084/004
|
Zoetis Belgium S.A., Beļģija
|
QM01AH92
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Mavacoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer (Heinrich Mack Nachf), Vācija
|
| Date of authorisation/renewal: |
22-Sep-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/084/004 |
75 mg/tabl. |
2 |
Alumīnija blisteris, 1 tablete |
-
|
|
|
Metacam
|
5 mg/ml
|
EU/2/97/004/037
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Labiana Life Sciences S.A., Spānija
|
| Date of authorisation/renewal: |
06-Dec-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/004/037 |
5 mg/ml |
1 |
Flakons, 50 ml |
-
|
|
|
Emepax 160 mg
|
160 mg
|
EU/2/26/363/015
|
Axience, Francija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Maropitant citrate monohydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
26-Mar-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/363/015 |
|
10 |
OPA/Al/PVH-Al blisteris, 4 tablete |
-
|
|
|
BRAVECTO CombiUNO
|
-
|
EU/2/25/350/007
|
Intervet International B.V., Nīderlande
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
30-Jul-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/350/007 |
|
1 |
Blisteris, 1 tablete |
-
|
|
|
Zulvac BTV
|
-
|
EU/2/17/207/009
|
Zoetis Belgium S.A., Beļģija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Manufacturing Research Spain S L, Spānija
|
| Date of authorisation/renewal: |
26-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/207/009 |
|
1 |
Polietilēna pudele, 120 deva |
-
|
|
|
Bravecto Plus
|
-
|
EU/2/18/224/003
|
Intervet International B.V., Nīderlande
|
QP54AB52
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet UK Ltd, Lielbritānija
|
| Date of authorisation/renewal: |
08-May-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/224/003 |
|
1 |
PP/Al pipete, 0,89 ml |
-
|
|
|
Nobilis IB 4 - 91
|
-
|
EU/2/98/006/012
|
Intervet International Booxmer, Nīderlande
|
QI01AD07
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for suspension
|
| International name (active substance): |
Live attenuated Infectious Bronchitis virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
21-May-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/98/006/012 |
|
10 |
Polipropilēna trauciņš, 5000 deva |
-
|
|
|
BRAVECTO CombiUNO
|
-
|
EU/2/25/350/014
|
Intervet International B.V., Nīderlande
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
30-Jul-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/350/014 |
|
3 |
Blisteris, 1 tablete |
-
|
|
|
Profender tablets for small dogs
|
-
|
EU/2/05/054/021
|
Vetoquinol S.A., Francija
|
QP52AA51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
modified-release tablets
|
| International name (active substance): |
Praziquantel,Emodepside
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
29-Jul-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/05/054/021 |
15 mg/3 mg |
24 |
Alumīnija blisteris, 1 tablete |
-
|
|
|
PREVEXXION RN+HVT
|
0.2 ml
|
EU/2/23/302/001
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI01AD03
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
concentrate and solvent for suspension for injection
|
| International name (active substance): |
Cell-associated live recombinant Marek’s disease (MD) virus, serotype 1,strain RN1250, Cell-associated, live attenuated Marek’s disease (MD) virus, serotype 3,strain HVT FC126
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS , Francija
|
| Date of authorisation/renewal: |
24-Oct-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/302/001 |
|
5 |
Stikla ampula, 1000 deva |
-
|
|
|
Contacera
|
20 mg/ml
|
EU/2/12/144/004
|
Zoetis Belgium S.A., Beļģija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande;Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
15-Nov-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/144/004 |
20 mg/ml |
1 |
Flakons, 250 ml |
-
|
|
|
Nobivac L4
|
-
|
EU/2/12/143/001
|
Intervet International B.V, Nīderlande
|
QI07AB01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000),L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001),L. interrogans serogroup Australis serovar Bratislava (strain As-05-073),L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
15-Jul-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/143/001 |
1 deva |
5 |
Flakons, 1 deva |
-
|
|
|
Poulvac E.Coli
|
-
|
EU/2/12/140/002
|
Zoetis Belgium S.A., Beļģija
|
QI01AE04
|
turkeys; chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Lyophilisate for suspension for spray vaccination
|
| International name (active substance): |
Live aroA gene deleted Escherichia coli, type O78, strain EC34195
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Manufacturing & Research Spain S.L., Spānija
|
| Date of authorisation/renewal: |
15-Jun-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/140/002 |
|
10 |
Stikla flakons, 2500 deva |
-
|
|
|
Masivet
|
150 mg
|
EU/2/08/087/002
|
AB Science S.A., Francija
|
QL01XE90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Masitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CRID PHARMA, Francija;Centre Spécialités Pharmaceutiques, Francija
|
| Date of authorisation/renewal: |
17-Nov-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/087/002 |
150 mg/tabl. |
30 |
Pudelīte, 1 tablete |
-
|
|
|
DuOtic
|
-
|
EU/2/24/327/001
|
Dechra Regulatory B.V., Nīderlande
|
QS02CA90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
ear gel
|
| International name (active substance): |
Terbinafine, Betamethasone acetate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
22-Nov-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/327/001 |
|
2 |
Tūbiņa, 1 deva |
-
|
|
|
LETIFEND
|
-
|
EU/2/16/195/008
|
Laboratorios LETI, S.L. unipersonal, Spānija
|
QI07A
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for solution for injection
|
| International name (active substance): |
Recombinant Protein Q from Leishmania infantum MON-1
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
20-Apr-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/16/195/008 |
|
100 |
Stikla flakons, 1 deva |
-
|
|
|
GUMBOHATCH
|
-
|
EU/2/19/245/002
|
Laboratorios Hipra S.A., Spānija
|
QI01AD09
|
chickens; embryonated chicken eggs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live attenuated infectious bursal disease virus (IBDV), strain 1052
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
12-Nov-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/245/002 |
|
10 |
Stikla flakons, 2000 devas/flakonā |
-
|
|
|
Poulvac E.Coli
|
-
|
EU/2/12/140/008
|
Zoetis Belgium S.A., Beļģija
|
QI01AE04
|
turkeys; chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Lyophilisate for suspension for spray vaccination
|
| International name (active substance): |
Live aroA gene deleted Escherichia coli, type O78, strain EC34195
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Manufacturing & Research Spain S.L., Spānija
|
| Date of authorisation/renewal: |
15-Jun-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/140/008 |
|
10 |
Stikla flakons, 20000 deva |
-
|
|
|
EVICTO
|
15 mg
|
EU/2/19/242/002
|
VIRBAC, Francija
|
QP54AA05
|
cats ≤ 2,5 kg; dogs ≤ 2,5 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
19-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/242/002 |
60 mg/ml |
4 |
Polipropilēna pipete, 0,25 ml |
-
|
|
|
Equioxx
|
8.2 mg/g
|
EU/2/08/083/004
|
AUDEVARD , Francija
|
QM01AH90
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
paste for oral use
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
06-Jun-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/083/004 |
8,2 mg/g |
7 |
Polipropilēna šļirce, 7,32 g |
-
|
|